Pepper Kara, Jaowattana Uraporn, Starsiak Michael D, Halkar Raghuueer, Hornaman Kelly, Wang Wenli, Dayamani Priya, Tangpricha Vin
Division of General Internal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
J Gen Intern Med. 2007 Jul;22(7):1042-6. doi: 10.1007/s11606-007-0189-1. Epub 2007 Apr 19.
We report a case of a 62-year-old woman with renal cell carcinoma (RCC) presenting with a hypercalcemia-induced coma. A laboratory evaluation indicated nonparathyroid-mediated hypercalcemia with an initial serum calcium level of 18.6 mg/dL. Our patient's parathyroid hormone (PTH)-related peptide level was undetectable. Initial imaging was negative, but PET scan identified a mass in the upper pole of the left kidney. Our patient underwent partial nephrectomy, and the mass was identified as RCC on final pathology. After surgery, her hypercalcemia resolved and PTH returned to normal limits. This case report describes a patient with RCC with the unusual presentation of hypercalcemic coma. We review the differential diagnosis of malignant hypercalcemia and the evaluation of hypercalcemia occurring with RCC. This case illustrates the need to carefully review and interpret all available data, especially when conventional testing in the work-up of hypercalcemia is unrevealing.
我们报告一例62岁患有肾细胞癌(RCC)的女性,其因高钙血症诱发昏迷。实验室评估显示为非甲状旁腺介导的高钙血症,初始血清钙水平为18.6mg/dL。我们患者的甲状旁腺激素(PTH)相关肽水平检测不到。初始影像学检查结果为阴性,但PET扫描发现左肾上极有一个肿块。我们的患者接受了部分肾切除术,最终病理检查确定该肿块为肾细胞癌。术后,她的高钙血症得到缓解,PTH恢复到正常范围。本病例报告描述了一名患有肾细胞癌且表现为高钙血症昏迷这一不寻常症状的患者。我们回顾了恶性高钙血症的鉴别诊断以及肾细胞癌伴发高钙血症的评估。该病例说明需要仔细审查和解读所有可用数据,尤其是在高钙血症检查的常规检测未发现异常时。